The invention also concerns the resulting active principle and cosmetic compositions incorporating said active principle.
Described is a pharmaceutical and/or cosmetic preparation for topical application, the preparation containing, in addition to at least one active principle, a carrier material designed to convey the active principle into the skin.
More preferably the active ingredient comprises at least one suitable pharmaceutical active ingredient, cosmetic active ingredient, toiletries active ingredient and/or any compatible mixture thereof.
The form of administration consists of an inner section containing the active ingredient and surrounded by a coating, free of the active ingredient, in such a manner that the active ingredient is released rapidly.
The pellets can be obtained by spraying active-ingredient-containing granules with a solvent for the active ingredient or with an active-ingredient-containing liquid.
When Ca is used in the PAM delivery product, it is present in a 9:1 ratio to the PAM There are no fixing agents needed in the PAM delivery product; it is pure active ingredient.
An active ingredient is added.
The inventive laminates containing an active substance have a high content of active substances and effect a high active substance flux throughout the skin.
The active agent formulation includes an active agent and an aqueous liquid component.
The active kibbles can be mixed with non-active kibbles.
The active is a hydrophobic active, typically a high-dose active.
Also disclosed are compositions containing the treated castor oil and an active agent such as a pharmaceutical agent.
An encapsulated ingredient is disclosed comprising an ingredient component and a coating component.
The barrier is interposed between the active agent component and the adverse agent component.
This product is an intermediate product in the synthesis of cough-relieving dextromethorphanne and analgesic levorphanol.
The composition includes an active agent or the active agent is added during administration of the composition.
The compositions combine an anti-infective and/or antimicrobial active agent in a carrier.
Said medicament or combination of medicaments contains at least one active agent and at least one antagonist of said active agent.
The continuous phase is then removed from the polymer/active agent solution, thereby forming a solid polymer/active agent matrix.